Maccecchini Maria-Luisa 4
4 · Lantern Pharma Inc. · Filed Jan 13, 2026
Insider Transaction Report
Form 4
Maccecchini Maria-Luisa
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-01-09+25,000→ 25,000 totalExercise: $3.49Exp: 2036-01-08→ Common Stock (25,000 underlying) - Award
Stock Option (Right to Buy)
[F2]2026-01-09+21,152→ 21,152 totalExercise: $3.49Exp: 2036-01-08→ Common Stock (21,152 underlying)
Footnotes (2)
- [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing February 9, 2026.
- [F2]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 12-month period commencing February 9, 2026.
Signature
/s/ Maria Luisa Maccecchini|2026-01-12